Blazejczyk Magdalena, Macias Matylda, Korostynski Michal, Firkowska Marcelina, Piechota Marcin, Skalecka Agnieszka, Tempes Aleksandra, Koscielny Alicja, Urbanska Malgorzata, Przewlocki Ryszard, Jaworski Jacek
International Institute of Molecular and Cell Biology, 4 Ks. Trojdena St., 02-109, Warsaw, Poland.
Institute of Pharmacology, Polish Academy of Sciences, 12 Smetna St, 31-343, Krakow, Poland.
Mol Neurobiol. 2017 May;54(4):2562-2578. doi: 10.1007/s12035-016-9821-6. Epub 2016 Mar 19.
Epileptogenesis is a process triggered by initial environmental or genetic factors that result in epilepsy and may continue during disease progression. Important parts of this process include changes in transcriptome and the pathological rewiring of neuronal circuits that involves changes in neuronal morphology. Mammalian/mechanistic target of rapamycin (mTOR) is upregulated by proconvulsive drugs, e.g., kainic acid, and is needed for progression of epileptogenesis, but molecular aspects of its contribution are not fully understood. Since mTOR can modulate transcription, we tested if rapamycin, an mTOR complex 1 inhibitor, affects kainic acid-evoked transcriptome changes. Using microarray technology, we showed that rapamycin inhibits the kainic acid-induced expression of multiple functionally heterogeneous genes. We further focused on engulfment and cell motility 1 (Elmo1), which is a modulator of actin dynamics and therefore could contribute to pathological rewiring of neuronal circuits during epileptogenesis. We showed that prolonged overexpression of Elmo1 in cultured hippocampal neurons increased axonal growth, decreased dendritic spine density, and affected their shape. In conclusion, data presented herein show that increased mTORC1 activity in response to kainic acid has no global effect on gene expression. Instead, our findings suggest that mTORC1 inhibition may affect development of epilepsy, by modulating expression of specific subset of genes, including Elmo1, and point to a potential role for Elmo1 in morphological changes that accompany epileptogenesis.
癫痫发生是一个由初始环境或遗传因素触发的过程,该过程会导致癫痫,并且在疾病进展过程中可能持续存在。这一过程的重要部分包括转录组的变化以及神经元回路的病理性重新布线,其中涉及神经元形态的改变。哺乳动物/雷帕霉素作用靶点(mTOR)会被惊厥药物(如红藻氨酸)上调,并且是癫痫发生进展所必需的,但对其作用的分子机制尚未完全了解。由于mTOR可以调节转录,我们测试了雷帕霉素(一种mTOR复合物1抑制剂)是否会影响红藻氨酸诱发的转录组变化。利用微阵列技术,我们发现雷帕霉素可抑制红藻氨酸诱导的多个功能异质基因的表达。我们进一步聚焦于吞噬与细胞运动蛋白1(Elmo1),它是肌动蛋白动力学的调节剂,因此可能在癫痫发生过程中对神经元回路的病理性重新布线起作用。我们发现,在培养的海马神经元中长时间过表达Elmo1会增加轴突生长、降低树突棘密度并影响其形状。总之,本文提供的数据表明,红藻氨酸诱导的mTORC1活性增加对基因表达并无全局影响。相反,我们的研究结果表明,mTORC1抑制可能通过调节特定基因子集(包括Elmo1)的表达来影响癫痫的发展,并指出Elmo1在癫痫发生伴随的形态学变化中可能发挥的作用。